XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Ordinary Shares
Preferred Shares
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of the period (in shares) at Dec. 31, 2021   683,100,000 14,400,000      
Balance at beginning of the period at Dec. 31, 2021 $ 11,925.9 $ 11,827.9 $ 1,392.6   $ 326.7 $ (1,604.4)
Balance at beginning of the period (in shares) at Dec. 31, 2021       500,000    
Balance at beginning of the period at Dec. 31, 2021       $ 16.9    
Increase (Decrease) in Shareholders' Equity            
Reclassification of EBT Shares   (500,000)        
Exercise of stock options (in shares)   200,000        
Exercise of stock options 0.4 $ 0.4        
Vesting of restricted stock units (in shares)   700,000        
Share-based award activity (in shares)   (400,000)        
Share-based award activity $ 21.5 $ 21.5        
Repurchase of ordinary shares (in shares) (4,100,000) (4,100,000)   (4,100,000)    
Repurchase of ordinary shares $ (66.4)     $ (66.4)    
Retirement of treasury shares (in shares) (2,100,000)     (2,100,000)    
Retirement of treasury shares $ (33.3) $ (34.8)   $ 33.3   1.5
Sale of treasury shares (in shares) 41,700     0    
Sale of treasury shares $ 0.6     $ 1.3   (0.7)
Dividends to preferred shareholders (18.7)         (18.7)
Net income (loss) 69.5         69.5
Other comprehensive income (loss) (223.2)       (223.2)  
Balance at end of the period (in shares) at Mar. 31, 2022   679,000,000.0 14,400,000      
Balance at end of the period at Mar. 31, 2022 11,709.6 $ 11,815.0 $ 1,392.6   103.5 (1,552.8)
Balance at end of the period (in shares) at Mar. 31, 2022       2,500,000    
Balance at end of the period at Mar. 31, 2022       $ (48.7)    
Balance at beginning of the period (in shares) at Dec. 31, 2022   674,400,000 14,400,000      
Balance at beginning of the period at Dec. 31, 2022 $ 6,812.5 $ 11,744.7 $ 1,392.6   (665.9) (5,658.9)
Balance at beginning of the period (in shares) at Dec. 31, 2022 0     0    
Balance at beginning of the period at Dec. 31, 2022       $ 0.0    
Increase (Decrease) in Shareholders' Equity            
Vesting of restricted stock units (in shares)   1,800,000        
Share-based award activity (in shares)   (600,000)        
Share-based award activity $ 33.7 $ 33.7        
Repurchase of ordinary shares (in shares) 0          
Repurchase of ordinary shares $ 0.0          
Retirement of treasury shares (in shares) 0          
Retirement of treasury shares $ 0.0          
Dividends to preferred shareholders (18.8)         (18.8)
Net income (loss) 43.5         43.5
Other comprehensive income (loss) 88.4       88.4  
Balance at end of the period (in shares) at Mar. 31, 2023   675,600,000 14,400,000      
Balance at end of the period at Mar. 31, 2023 $ 6,959.3 $ 11,778.4 $ 1,392.6   $ (577.5) $ (5,634.2)
Balance at end of the period (in shares) at Mar. 31, 2023 0     0    
Balance at end of the period at Mar. 31, 2023       $ 0.0